The Research and Manufacturing Center was recently opened by Sarepta Therapeutics in Andover, leading the way to the doubling of its workforce in the location over the next year to year-and-a-half and perhaps increasing business card printing orders in the area.
Currently, 50 people work at the facility, focusing on increasing the company’s efforts in research and development for its Duchenne muscular dystrophy (DMD) treatment. It could have up to seven such investigational treatments that have the potential to go into clinical trials by the end of the year.
Since 2013, Sarepta has been based in Massachusetts, with Cambridge becoming its headquarters in 2014. That same year, Sarepta announced that it would be expanding investigational DMD treatments, resulting in clinical trials by the end of the year. It then purchased the current site in Andover, measuring 26 acres, which was shut down by Japanese company Eisai the previous year. In 2016, Sarepta moved all its operations from Corvallis, Oregon to the Commonwealth.
A director on the Board of Trustees of Sarepta board and a special regulatory and scientific advisor to the company, Edward M. Kaye, M.D., said that the company has benefited from the highly educated and talented workforce in Massachusetts, and added that the expansion demonstrates the company’s commitment to investing in the state’s vibrant economy.
Location
362 N. Main Street
Andover, MA 01810
Get Directions →
Phone
Hours
Mon: 8:00 - 5:00
Tue: 8:00 - 5:00
Wed: 8:00 - 5:00
Thu: 8:00 - 5:00
Fri: 8:00 - 5:00
Sat: Closed
Sun: Closed